Want to join the conversation?
In 3Q16, $USB's return on average common equity was 13.5% and efficiency ratio was 54.5%. Credit quality was stable in the quarter as expected. Both nonperforming assets and net charge-offs decreased modestly compared with the prior linked quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?